DISEASE SCANNER

Global Incurable Diseases Tracker

Back to Globe
Infectious Disease

COVID-19

HIGH SEVERITY

Respiratory illness caused by SARS-CoV-2 virus. Global pandemic 2020-2023. Range from asymptomatic to severe pneumonia, ARDS, death. Long COVID affects millions.

Global Affected

775.0M

Countries

111

Symptoms

Fever
Cough
Shortness of breath
Fatigue
Loss of taste/smell
Sore throat
Muscle aches
Headache
Chills
Nausea
Diarrhea
Pneumonia
ARDS
Blood clots

Treatment Options

Supportive care
Antivirals (Paxlovid, molnupiravir)
Remdesivir
Monoclonal antibodies (bebtelovimab)
Corticosteroids (dexamethasone for severe)
IL-6 inhibitors (tocilizumab)
JAK inhibitors (baricitinib)
Vaccination

Risk Factors

1Age >65
2Obesity
3Diabetes
4Cardiovascular disease
5Chronic lung disease
6Immunocompromise
7Smoking
8Pregnancy
9Chronic kidney disease
10Cancer

Diagnostic Methods

  • 1RT-PCR (nasopharyngeal swab)
  • 2Rapid antigen tests
  • 3Chest CT
  • 4Blood tests (D-dimer, CRP)
  • 5Pulse oximetry
  • 6Whole genome sequencing (variants)

Prognosis

Case fatality 0.5-1% overall. Age-dependent: <0.1% in children, 5-15% in elderly. Long COVID affects 10-20% of cases. Vaccination reduces severe disease 90%+.

Prevention

  • Vaccination (primary and boosters)
  • Masks (high-quality N95/KN95)
  • Hand hygiene
  • Physical distancing
  • Ventilation
  • Testing and isolation
  • Antiviral prophylaxis (high-risk)

Research Status

mRNA vaccines revolutionized vaccinology. Antivirals (Paxlovid, molnupiravir) reduce severe disease. Monoclonal antibodies for high-risk. Evolving variants (Omicron subvariants). Long COVID research ongoing. Intranasal vaccines in trials.

Sources

  • https://www.cdc.gov
  • https://www.who.int
  • https://www.hematology.org/education/patients
  • https://www.ncbi.nlm.nih.gov/books
  • https://rarediseases.org/rare-diseases

Medical Disclaimer

This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.